Perrigo announced Wednesday that it completed its $8.6-billion acquisition of Elan. "We are very pleased to welcome the Elan team into the Perrigo family," said CEO Joseph Papa, adding "the combined company establishes a diversified platform that will position Perrigo well for further expansion."
The company also said it has appointed its board of directors, including naming Papa as board chairman, until Perrigo's annual general meeting scheduled for November 2014. The company's 11-member board will be composed of all of the former members of Perrigo's board of directors.
Perrigo's acquisition of Elan, which put itself up for sale earlier this year after rejecting takeover offers of as much as $8 billion from Royalty Pharma in June, was approved by Ireland's Supreme Court earlier this week.
To read more Top Story articles, click here.